Dysregulated glucose-induced insulin secretion is a well-established feature of T2D (83–87) and also reported in T1D patients prior to disease onset (88–92), suggesting a possible link between insulin secretory defects and activation of inappropriate autoimmune responses. This evidence concerns the gene INS and type 2 diabetes mellitus.